Clearsight Advisors, Inc. has announced a successful transaction in its Healthcare & Life Sciences Consulting practice. Clearsight served as the exclusive advisor to Kx Advisors, LLC in its acquisition by BGB Group, LLC, a portfolio company of Tarrant Capital IP, LLC dba TPG.
Kx Advisors is a health care consultancy providing growth strategy services to leading pharmaceutical, biotechnology and medical technology companies. With offices in Washington, Boston and London, the Kx team delivers data-driven analyses and global insights to develop holistic strategies for their clients. The company's key capabilities include corporate strategy and franchise planning, market expansion and forecasting, mergers and acquisitions advisory, new product planning, pricing and market access, and brand planning and launch strategy. BGB Group is an agency focused on health care advertising, medical communications, strategic consulting, and payer and market access. Together with the backing of TPG, Kx and BGB will bring together decades of experience helping top pharmaceutical and medical device companies achieve scientific and commercial success.
Bob Serrano, Managing Partner at Kx, commented on the transaction, "Clearsight's dedication and nuanced understanding of the healthcare and life sciences sector sets them apart from other banks. With Clearsight's guidance, we were able to better navigate this deal process and maximize value for our business and employees. As a result, we are pleased to embark on our new partnership with BGB and TPG, where we see tremendous strategic and cultural synergies."
